GlassScriptPhysician profile
Luke Wendt
NPI 1841618972
$1,353.77
in general payments reported to CMS, 2019-2025
19 companies · $169 in 2025
The $169 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $20.56 · 2021: $206 · 2022: $394 · 2023: $197 · 2024: $266 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $353.44 | 2021-2025 | Acessa Provu System, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Channel Medsystems, INC. | $115.46 | 2022 | |
| Femselect INC. | $106.20 | 2024 | Enplace |
| Daiichi Sankyo INC. | $88.12 | 2021-2023 | Injectafer |
| Therapeuticsmd, INC. | $82.66 | 2019-2021 | |
| Intuitive Surgical, INC. | $78.18 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.50 | 2021-2024 | |
| Abbvie INC. | $68.85 | 2021-2023 | Liletta |
| Exeltis, USA INC. | $67.78 | 2021-2023 | Slynd |
| Organon LLC | $62.70 | 2022-2023 | |
| Astellas Pharma US INC | $59.59 | 2023-2024 | Veozah |
| Ethicon US, LLC | $52.35 | 2021-2024 | Dermabond, Vistaseal, Stratafix |
| Biogen, INC. | $38.10 | 2024 | Zurzuvae |
| Allergan, INC. | $37.92 | 2019 | |
| Evofem Biosciences, INC. | $17.14 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic INC | $16.68 | 2021 | |
| Merck Sharp & Dohme LLC | $14.85 | 2022 | |
| Virtus Pharmaceuticals LLC | $12.19 | 2021 | |
| Lupin INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Wendt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.